IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.
Autor: | Mondesir, Johanna1,2, Willekens, Christophe3,4,5, Touat, Mehdi6,7, de Botton, Stéphane3,4,5 stephane.debotton@igr.fr |
---|---|
Zdroj: | Journal of Blood Medicine. Sep2016, Vol. 7, p171-180. 10p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |